Evidence map›Paper›PMID 34393778›Full record

ArticleFrontiers in pharmacology2021

Qingda Granule Attenuates Angiotensin II-Induced Blood Pressure and Inhibits Ca

Meizhu Wu, Xiangyan Wu, Ying Cheng, Zhiqing Shen, Xiaoping Chen, Qiurong Xie, Jianfeng Chu, Jiapeng Li, Liya Liu, Lihui Wei and 4 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Meizhu WuAcademy of Integrative Medicine, Fuzhou, China.
Xiangyan WuAcademy of Integrative Medicine, Fuzhou, China.
Ying ChengAcademy of Integrative Medicine, Fuzhou, China.
Zhiqing ShenAcademy of Integrative Medicine, Fuzhou, China.
Xiaoping ChenAcademy of Integrative Medicine, Fuzhou, China.
Qiurong XieAcademy of Integrative Medicine, Fuzhou, China.
Jianfeng ChuAcademy of Integrative Medicine, Fuzhou, China.
Jiapeng LiDepartment of Physical Education, Fujian University of Traditional Chinese Medicine, Fuzhou, China.
Liya LiuAcademy of Integrative Medicine, Fuzhou, China.
Lihui WeiAcademy of Integrative Medicine, Fuzhou, China.
Linzi LongAcademy of Integrative Medicine, Fuzhou, China.
Qiaoyan CaiAcademy of Integrative Medicine, Fuzhou, China.
Jun PengAcademy of Integrative Medicine, Fuzhou, China.
Aling ShenAcademy of Integrative Medicine, Fuzhou, China.
Fujian University of Traditional Chinese Medicine · CNXiyuan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

angiotensin IICa2+/ERK signaling pathwayhypertensionQingda granulevascular smooth muscle cells

Identifiers

PMID34393778
PMCPMC8358933
OpenAlexW3183791569

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.